chrisvoncsefalvay/vaers-outcomes huggingface dataset:
79 Yr old pt had Covid Vaccine 2nd injection on Tuesday. Pt became ill on Tuesday noc with generalized bodyaches and loose stools. No fever. No cough nor HA.  No redness nor swelling of arm. Injection was the Moderna. Last voided this evening. Last normal meal was AM of vaccine injection.  2.  Increased dependent lung base atelectasis 3. Mild gallbladder wall edema suggesting choleycystitis.  No biliary ductal dilitation or calcified stone. 4.  Mild pancreatitis without abscess or necrosis 5.  Colonic diverticulosis without diverticulitis.    Impression:  1. Mild-Moderate Dehydration  2. Reaction to second dose of Covid -19 Moderna vaccine  3. Elevated LFT's suggesting CD Obstruction 4. Elevated wbc most likely related  to #3 or #5  5. Bibasilar atelectasis with low lung volumes and accounting for Hypoxia; suspect related to #6        6. Acute Pancreatitis with Amylase 348 and Lipase 1109  7. Elevated D Dimer ; DISCHARGE SUMMARY   Date of Admission:  2/11/2021 Date of Discharge:  02/12/2021   Admitting Diagnosis:  Acute pancreatitis, acute cholecystitis Discharge Diagnosis:  Acute pancreatitis, acute cholecystitis, sepsis   History of Present Illness: Pt presented with 2 days of generalized malaise, abd pain, and diarrhea, starting shortly after his second Moderna COVID-19 vaccination. In the ER, he was found to have acute pancreatitis and cholecystitis as determined by CT scan and U/S without biliary tree involvement. Given new O2 requirements, CT chest performed and was negative. Labs showed elevated amylase/lipase, elevated bilirubin, AST/ALT/alk phos. Disposition:  Transfer to Medical Center for further management  Condition: Fair
A few days after receiving the vaccine, I went to the emergency room as I was sweating profusely. I was there for observation and released. In 05/2022 I tested positive for COVID-19. My symptoms were very mild, and I did not go to the doctor. I started feeling sick and ached all over on 12/06/2022 and threw up. I went to the emergency room on 12/07/2022 and was diagnosed with viral double pneumonia. I was admitted to the hospital until 12/09/2022. I have been diagnosed with low IGG and I have to have plasma infusions two times a month for the rest of my life. I have been in the hospital seven times in 2022.
Patient presented to the ED with altered mental status for the past 2 days. Patient admitted as observation on 6/14/2022 due to Type 2 diabetes mellitus with hyperosmolar hyperglycemic state (HHS). Patient was tested for COVID-19 and was positive on 6/13/22.
As soon as I received the vaccine , I felt the same as if I were stung by a bee.  I  felt warm and I could feel my tongue getting numb.  I told the pharmacist & after about 15 minutes I asked if I could take my Benadryl.  So it sort of slowed it down but I still had the tingling and numbing .  It?s been  3 days and I?m still experiencing the numbing of my tongue .
Hives swollen face and got anaphylactic shock bith both 1 and 2 series of pfizer vaccine  Also got pericarditis  was treated with predisone  and benadryl  also with an ansthma inhaler and got referred to see a cardiologist to check my heart because EKG showed possible LEft Atrial Enlargement but tests showed no LAE it is pericarditis
Subsequent to receiving one dose of varicella virus vaccine live on 9/19/96, the pt developed chickenpox with a general rash with a low number of lesions, on 4/26/99. The pt sought unspecified medical attention.
SWOLLEN ARM. A BIG RED SPOT ABOUT 4 ICHES AND PAIN TO THE COLLORBONE AND PAIN IN A LYMPH NOTE. IS GETTING WORSE.
8x8 cm red patch; sl raised, pruritic in lt upper arm; swelling & edema dec, looks much better; pt leaving country for 1month
Patient received her covid booster on 12/6/21 at pharmacy, reported on Christmas she cannot smile correctly, lift forehead or wink on left side of face. No motor weakness, numbness. No skin lesions, tick bites, etc. Patient was started on prednisone, famicyclovir and valacyclovir at telephone visit 1/3/22 by PCP. Patient then had in-office visit on 3/7/22 reporting symptoms did not resolve though did improve following the above medications.  Provider noted "this facial palsy is MUCH more consistent with a Central 7th and NOT a peripheral 7th as she can wrinkle her forehead on the left side that is not consistent with Bell's Palsy". CBC and Brain MRI were ordered, no acute abnormality noted on imaging or labwork. Patient seen 6/14- continues with symptoms but reports 99% improved.  Lyme reflex ordered which was also negative.
pt recvd vax & was given apap; grandma noted lt arm turned blue; pt started shaking like sz & coughing like choking; t100 R; rash noted; did not take to the MD; rubbed alcohol on pt; noted no further problems.
Initially bleeding and swelling at injection site (believe  it hit a blood vessel), immediately hit with a wave of dizziness, fast heart rate and tingling in throat.  Since being home injection site has bruised and I have red streaking down the front of my arm with terrible pain and swelling.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 16-APR-2015 the patient was vaccinated with a dose of improperly stored (Merck) VARIVAX (strength, route, lot# and dose were unknown). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore arm and shoulder. Soreness of shoulder continuing weeks later. At the time of vaccine, the person giving the injection gave it quite high on my arm. I wondered about that at the time, and the next day when a very large bruise appeared at the injection site I figured that she had done it there because she may have known that a large bruise was likely and she thought it would not be as visible higher on the arm. I had never had an injection given that close to my shoulder. The pain is like tendinitis.
My arm was sore by the evening the vaccine was administered.  I woke up the following morning with fever, chills, body aches, and headache.  By Monday, I was still experiencing those same symptoms.  Tuesday and Wednesday, I had a headache and sweating a lot.  I also starting feeling lightheaded and dizzy losing focus on Wednesday and feeling nauseous and tired.  Thursday, I was unfocused, dizzy, slight headache, and very tired.  I could feel PVCs the majority of the week.
NAUSEA, ITCHY THROAT, FLUSH FACE, ITCHY LEGS.
Pt came to pharmacy complains of sore shoulder and inability to lift shoulder above head or complete daily functions without pain. Reported feeling sting during vaccination.
Right side lymphadenopathy on neck with redness and swelling at injection site. Painful swallowing.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On 31-JUL-2014 the patient was vaccinated with 0.5ml expired dose of VARIVAX (Merck) (injection, lot # H014272, expiration date 25-JUL-2014, subcutaneous). Concomitant medications were not provided. No adverse effect was reported. Additional information has been requested.
No adverse event; Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.) and NO ADVERSE EVENT (No adverse event) in a 29-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jan-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.).    The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.
Havix vaccine was given inappropriate schedule administration, called manufacturer of vaccine.  Pt had received one dose of vaccine prior to this one. No ill effects.
Patient's right arm is swollen, warm to the touch and painful from shoulder to elbow.  She has also had chills, no documented fevers, but has been taking Tylenol.  Patient came to office on 11/21/2013 at 2:30 PM for evaluation.  Treatment plan: Medrol dose pack, Benadryl 50 mg every 6 hours as needed.  She will return on Monday for a recheck. ER over the weekend if worse in any way.
CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-MAY-2021, the subject experienced confirmed covid-19 infection. Laboratory data included: Polymerase chain reaction (NR: not provided) Positive. Treatment medications included: favipiravir. The action taken with covid-19 vaccine was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was non-serious.
38 year old man received first dose of Anthrax vaccine. Within approximately one week he experienced vomiting, sore throat, body aches, and low grade fever.
Abdominal cramps and pain, nasal congestion and reddened mucosa, sore throat, slightly hoarse voice, malaise, myalgias and headache, all within 24 hours of receiving vaccines.
PT WAS ADMINISTERED AN EXPIRED FLU VACCINE. STAFF HAS CONTACTED OUR MEDICAL DIRECTOR AND HE ADVISED STAFF TO CONTACT PATIENT, WHICH WE DID AND INFORM HIM OF THE EXPIRED VACCINE AND ALSO LET THEM KNOW THERE WILL BE NO HARM TO HIM. PT HAS BEEN INFORMED
the patient complained of redness at the injection site after receiving the Flublok; Initial information regarding an unsolicited valid non-serious case received from the other health professional via phone at call center (Reference Number: US-SANOFI-00418826) received on 06-Jan-2021.  This case involved a 68-year old patient complained of redness at the injection site (Injection site erythema) after receiving INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (FLUBLOK QIV).  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 08-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE 0.5 mL (lot number: UJ455AA, expiry date: 17-Mar-2021) via an unknown route in the left deltoid for prophylactic vaccination.  On an unknown date, unknown latency, the patient complained of redness at the injection site after receiving the Flublok (Injection site erythema).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome was reported as unknown for the event of injection site erythema.
12:30 Heart palpating, sweating. 12:35 VS: 146/108,  HR 103, O2 96%. Left observation area at 12:45pm.
The Patient was sitting down to dinner and noticed when she tried to get up her left leg was very weak and she could not stand up without the aid of her husband and her cane which was highly abnormal, her leg also felt very cramped up and over the course of the night she felt very cold and could not warm up for the rest of the night, The next morning she woke up and reported she felt much better with much less weakness noticed in the leg and did not note any chills or muscle cramping, patient felt it was mostly gone by the following evening and was relieved.
Itchiness and hives all over my body including scalp, swollen eyes and forehead. Hives would multiply and get swollen if I scratched them.
After the flu shot, the severe symptoms developed immediately, including Chest Pain, heart Pain, muscle pain, fatigue, weakness, a fast heart beat, paleness. The  heart pain (heartstroke) has last more than one month. The symptom has not been improved.
Redness, raised bump, itching that continued to increase and get hot the next two days. Was seen in office on 9/18/10. Induration was approx 10x14cm.
The first symptoms I had were a sore throat and cough. I thought that the sore throat was the result of the cough, and the symptoms I had were similar to those of a common cold I had had in December 2022. I also had no fever. I also developed hoarseness. On 3/2/2023, I was tested for COVID-19 at an urgent care, and the result was positive. I was not prescribed Paxlovid, as the onset had taken place too many days prior, and I was already recovering. I then just isolated and continually improved. It took about two weeks for me to recover. I feel great now and don't have a cough.
Patient was nauseous and went to the restroom. I had my tech, follow him in there to ensure he was okay. The patient was trying to vomit but nothing came out, all he had was a gagging reflex. The patient asked for water so we gave it to him. He stated he felt better when his parents came to meet him up. He stayed past 15 minutes for observation to ensure he was okay.
Red skin rash surrounding the injection site about 3.5 - 4 inches long and 2 - 3 inches wide.
Chills; Fever; Aches; Fatigue; Headache; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient  received BNT162B2 (COMIRNATY, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, on unknown date, as dose 3(booster), single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (COMIRNATY, solution for injection; lot numbers and expiry dates were not reported) via an unspecified route of administration, on unknown date, as dose 1and dose 2, single for covid-19 immunisation. The patient experienced chills, fever, aches, fatigue and headache for 36 hours after booster. The outcome of the event was recovered on an unspecified date.  No follow-up attempts possible; information about lot/batch number cannot be obtained. No further information is expected.
whole body ache; dizziness; chills overnight; bad headache; Nausea; This is a spontaneous report from a non-contactable consumer (patient). A 17-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248; expiration date: not reported) first dose via an unspecified route of administration, administered in arm left on 14Jan2021 at 15:30 as 1st dose, single and second dose via an unspecified route of administration, administered in arm left on 04Feb2021 at 15:30 (lot number: EN5318; expiration date: not reported) as 2nd dose, single (age at vaccination was 17 years) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not receive any other vaccine in four weeks and had no COVID prior vaccination. On 05Feb2021 at 01:30, the patient experienced chills overnight, whole body ache, bad headache, dizziness, and nausea. No treatment for reported for the events. The patient had not COVID tested post vaccination. The outcome of the events was resolving.   No follow up attempts are possible. information about lot/batch number cannot be obtained.
This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient).  A 19-year-old male patient received the first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine) at single dose, on 05May2021, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient noticed some mucus build up, like a ball, in the back of his throat. Clinical outcome of the adverse event was unknown at time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
In February a few weeks after the vaccine, I started to feel more out of breath. I also noticed a change of  taste and smell. I went to my general physician and regular follow ups with cardiologist and pulmonologist. They did EKG, Cardio sonogram, usual set of breathing tests and lung CT scan. They increased my dose of Trelegy and cardiologist included Aspirin.
Heart rate of 85 bpm for seven hours; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient did not have any allergies to food, medications and other products. Concomitant medications taken within two weeks of vaccination included atorvastatin calcium (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced heart rate of 85 beats per minute for seven hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event heart rate of 85 beats per minute for seven hours was resolved on 15Apr2021 at 05:00.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
the physician stated the warts on her face were cleared; The physician gave three doses of GARDASIL 9, over an unspecified time frame, to the patient prior to her reaching 9 years old,; This spontaneous report was received from Physician and refers to a 7-year-old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On an unknown date, the patient was vaccinated with the first, second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (dose, vaccination scheme, frequency, lot number, expiration date, and route of administration were not provided) administered for prophylaxis. She was approximately 7 years old (product administered to patient of inappropriate age), with facial warts, and on 24-MAY-2023, the physician stated warts on her face were cleared (therapeutic response unexpected). The outcome of the event was not provided.  The causality assessment between the event Therapeutic response unexpected and the suspect vaccines was not reported.
Minimal pain in upper left arm at time of injection, roughly 8 hours later noticed increasing pain in upper arm, then throughout arm. Whole body pain, especially back. Severe, couldn?t sleep. Chills. Hot flashes and sweating (but no temperature-only checked it twice though). Horrible pain lasted roughly 40 hours, felt better around midnight Saturday night. Chills were gone but still sweating.
Took unrefrigerated dose; Spontaneous report received on 20FEB2020.  A pharmacist reported that a consumer "took unrefrigerated Vivotif" (PT: Product storage error). The consumer was receiving Vivotif capsule for immunisation. The consumer took the first dose of Vivotif which was left out of the refrigerator for 15 hours. The reporter could not confirm the exact temperature of the excursion or a lot number of Vivotif. Additionally, it was reported that the consumer did not take the dose of Vivotif with any liquid. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer took first dose of Vivotif which was unrefrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took first dose of Vivotif which was unrefrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as not applicable to Vivotif.
Patient called health clinic on 6/24/2022 to report that the evening before she went into A-fib and had to be seen by urgent care. She also was seen on 6/24/2022 by her PCP and talked with her cardiologist on 6/24/2022. She reports she had a prior history of A-fib but has been without an issue for 4 years until last evening. She is still currently in A-fib.
COVID Pfizer Bivalent 12+ dose administered to pt that is 11 years old on 4/1. On 4/4 the mother of the patient was informed of the error, she reported that the only side effect experienced was a sore arm. She was reminded of the signs and symptoms of myocarditis and pericarditis and care should be sought immediately if symptoms develop,
01/14/21 6:00 am noticed lump when running bar of soap over area.  later in day it started to turn pink and was slightly warm to touch. 01/15/2021 6:00 am noticed arm itching and upon inspection noticed Hard lump swelling; redness, hot to touch.
Patient obtained influenza vaccine from outpatient pharmacy. Approximately 4 hours after vaccination, patient developed a red, bumpy rash down both arms. After 24 hours of vaccination, rash extended to trunk of body. Patient took 1 dose of diphenhydramine 25 mg when she initially noticed the rash on the arms. Patient has never experienced an allergic reaction to the influenza vaccine in the past.
Patient got his 1st dose of Moderna Vaccine on14thApril2021; He´s still waiting for the 2nd dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient got his 1st dose of Moderna Vaccine on14thApril2021; He´s still waiting for the 2nd dose) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient got his 1st dose of Moderna Vaccine on14thApril2021; He´s still waiting for the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient got his 1st dose of Moderna Vaccine on14thApril2021; He´s still waiting for the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  Upon internal review on 04-AUG-2021, the age was corrected to 19 years.